Euronext N.V. (ENX.PA)
| Previous close | 73.00 |
| Open | 73.32 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 73.04 - 74.42 |
| 52-week range | 69.70 - 105.50 |
| Volume | |
| Avg. volume | 157,162 |
| Market cap | 7.889B |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | 17.25 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.47 (2.01%) |
| Ex-dividend date | 17 May 2021 |
| 1y target est | N/A |
- Reuters
Citi behind trade that caused brief European share plunge -sources, Citi
LONDON (Reuters) -The sudden fall in European shares driven by a brief crash in Nordic markets was caused by a single sell order trade by Citigroup Inc, people familiar with the matter told Reuters, and confirmed by Citi. The flash-crash, which caused European shares to suddenly fall on a day of holiday-thinned trading activity, involved an erroneous calculation relating to a Nasdaq Inc index involving Swedish companies, one source said. The Stockholm OMX 30 equity benchmark index was one of the hardest hit, falling by 8% at one point following a five-minute dive, before paring most of its losses to trade down 1.7% at 1229 GMT.
- Reuters
CVC plans to list on Euronext exchange rather than London - FT
The buyout firm has told potential investors it is aiming to list on Amsterdam's Euronext exchange and is targeting 25 billion euros for its next private equity fund, the newspaper said https://www.ft.com/content/831a0d91-ee4d-476c-bd69-8d87c533065f?FTCamp=engage/CAPI/app/Channel_Refinitiv//B2B, citing four people familiar with the matter. The private equity firm is looking to go public in the second half of the year with Goldman Sachs, JPMorgan and Morgan Stanley working on the plan.
- Reuters
Italy's Farmacosmo to list on Euronext Growth Milan
Italy's Farmacosmo, which operates in the health, pharma and beauty sector, said on Wednesday it had filed a request to list its shares on Euronext Growth Milan. The company said in a statement that the price for the offer, which will take place through a capital hike, was set in a range between 2.15 euros and 2.25 euros per share, resulting in a valuation of the company of above 70 million euros ($76.94 million).
